Appili Therapeutics Inc
APLI
Company Profile
Business description
Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes programs namely ATI-1701, ATI-1801.
Contact
1344 Summer Street
Suite 21
HalifaxNSB3H 0A8
CANT: +1 902 442-4655
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 March 2026
Employees
9
Stocks News & Analysis
stocks
Telstra earnings: No need to get hysterical over mobile
Earnings report in-line with expectations.
stocks
Market Minute: RBA cuts rates again, US CPI data released
This week, the RBA cut rates after a surprise hold in July; CBA reported earnings ; US inflation data came out, showing its highest reading since February.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,211.30 | 0.80 | -0.01% |
| CAC 40 | 7,923.45 | 53.11 | 0.67% |
| DAX 40 | 24,359.30 | 18.20 | -0.07% |
| Dow JONES (US) | 44,946.12 | 34.86 | 0.08% |
| FTSE 100 | 9,138.90 | 38.34 | -0.42% |
| HKSE | 25,290.01 | 19.94 | 0.08% |
| NASDAQ | 21,622.98 | 87.69 | -0.40% |
| Nikkei 225 | 43,757.84 | 379.53 | 0.87% |
| NZX 50 Index | 12,937.08 | 47.70 | 0.37% |
| S&P 500 | 6,449.80 | 18.74 | -0.29% |
| S&P/ASX 200 | 8,936.60 | 2.00 | -0.02% |
| SSE Composite Index | 3,733.79 | 37.02 | 1.00% |